Which GLP-1 is approved for PCOS?

None. No GLP-1 drug is FDA-approved for PCOS. Semaglutide and tirzepatide are approved for weight or diabetes, so any PCOS use is off-label, framed by the 2023 International PCOS Guideline as an adjunct where weight management is a goal.

Does a GLP-1 help PCOS symptoms beyond weight?

Weight reduction can improve insulin resistance and, in some women, ovulation regularity, but GLP-1 drugs are not approved to treat PCOS itself. Effects vary and should be evaluated by a clinician alongside your other PCOS care.

Can I get pregnant more easily on a GLP-1 with PCOS?

Weight loss can restore ovulation in some women with PCOS, which can affect fertility. If pregnancy is not intended, use reliable contraception; if it is, the labels advise stopping the drug beforehand. Discuss timing with a clinician.

By condition and life stage

What Is the Best GLP-1 for PCOS?

Medically reviewed by Editorial Medical Review, MD, NAMS-CMP · Updated July 2026

Quick answer

No GLP-1 drug is FDA-approved specifically for PCOS. When weight management is a treatment goal, the 2023 International PCOS Guideline lists anti-obesity medications as an adjunct, so semaglutide or tirzepatide may be used off-label. For women with PCOS, the molecule choice is a clinician decision, not a one-size-fits-all pick.

There is no PCOS-approved GLP-1

This is the most important fact to start with: the FDA has not approved any GLP-1 drug for polycystic ovary syndrome. Approvals are for chronic weight management (Wegovy, Zepbound) or type 2 diabetes (Ozempic, Mounjaro, Rybelsus). Any PCOS use is off-label and directed by a clinician.

The 2023 International Evidence-Based PCOS Guideline recognizes anti-obesity medications as an adjunct where weight management is a goal, which is the framework most clinicians use rather than a specific product endorsement.

Why weight and insulin resistance drive the choice

PCOS often involves insulin resistance, and weight reduction can improve metabolic markers and, in some women, restore more regular ovulation. Because tirzepatide showed a larger average weight reduction in its trials than semaglutide did in its own, magnitude of weight loss is one factor clinicians consider.

That said, larger trial weight loss is not automatically the right answer for an individual. Tolerability, cost, insurance coverage, and pregnancy plans all weigh into the decision, and none of these trials were designed specifically around PCOS outcomes.

The fertility and contraception angle

Because weight loss can restore ovulation in PCOS, reliable contraception matters if pregnancy is not intended. The tirzepatide label additionally warns it may reduce oral-contraceptive effectiveness, so a backup or non-oral method is advised for 4 weeks after starting and after each dose increase.

If pregnancy is the goal, the labels advise stopping the drug beforehand, which makes GLP-1 use and conception timing a specific conversation to have with a clinician.

Molecule choice vs provider choice

This page is about the molecule-level question. Choosing a telehealth provider that handles PCOS care is a separate decision, and our brand ranking covers that.

Key points

No GLP-1 is FDA-approved for PCOS; any use for PCOS-related weight is off-label.
The 2023 International PCOS Guideline treats anti-obesity medications as an adjunct.
Tirzepatide showed larger average trial weight loss; semaglutide is also widely used.
Weight loss can restore ovulation, so contraception and pregnancy timing matter.

Molecule facts (canonical explainers)

This is a decision guide. For the plain-fact explainer of each molecule (mechanism, FDA status, dosing cautions), see:

Zepbound for women — GIP/GLP-1 receptor dual agonist (tirzepatide)
Wegovy for women — GLP-1 receptor agonist (semaglutide 2.4 mg)

Providers we review in this area

Editorial reviews only — not treatment recommendations. Prescribing decisions rest with a licensed clinician. For the full directory, see all GLP-1 for women providers.

Allara — Comprehensive PCOS and hormonal health telehealth. Multidisciplinary care team including endocrinologists, dietitians, and mental health professionals.
Pollie (PCOS Specialist) — PCOS-focused platform with phenotype-driven treatment matching. Specialist providers only.
Pandia Health — Women-led birth control and women's health telehealth that includes PCOS-relevant care (hormonal birth control, spironolactone, metformin where appropriate).

Cost

PCOS-related GLP-1 costs track the underlying drug (roughly $349 to $599 self-pay for tirzepatide, about $499 for semaglutide). See the PCOS treatment cost guide for the full picture.

See the full cost breakdown in our How much does PCOS treatment cost?.

Frequently asked questions

Which GLP-1 is approved for PCOS?: None. No GLP-1 drug is FDA-approved for PCOS. Semaglutide and tirzepatide are approved for weight or diabetes, so any PCOS use is off-label, framed by the 2023 International PCOS Guideline as an adjunct where weight management is a goal.
Does a GLP-1 help PCOS symptoms beyond weight?: Weight reduction can improve insulin resistance and, in some women, ovulation regularity, but GLP-1 drugs are not approved to treat PCOS itself. Effects vary and should be evaluated by a clinician alongside your other PCOS care.
Can I get pregnant more easily on a GLP-1 with PCOS?: Weight loss can restore ovulation in some women with PCOS, which can affect fertility. If pregnancy is not intended, use reliable contraception; if it is, the labels advise stopping the drug beforehand. Discuss timing with a clinician.

Sources

Every efficacy, safety, and price claim above resolves to an FDA label, published trial, guideline, or manufacturer / GoodRx pricing page. External links open in a new tab.

Keep reading

ClearHormones updates these guides as FDA status and pricing change. Verify current approval status and pricing on the manufacturer or FDA page before acting.